Pharmaceutical

For volunteers at an eating disorder hotline, being rep...

“This is a job I undertook not only as somebody who is recovered from an eating ...

STAT+: Grail faces uphill battle to get Medicare to cov...

Medicare covers FDA-approved medicines and devices that help diagnose or treat d...

Opinion: A seemingly small semantic issue is a major ro...

Clarifying this distinction will help accelerate the development of cures for ra...

GSK obtains approval in Japan for shingles vaccine

The Japanese MHLW has granted approval for a renewed indication of GSK's shingle...

Tonix to acquire Upsher-Smith’s migraine products

Tonix Pharmaceuticals and Tonix Medicines have signed an agreement for the acqui...

EC approves BMS’ Camzyos for hypertrophic cardiomyopathy

The European Commission has approved Bristol Myers Squibb’s Camzyos to treat sym...

Vertex and Lonza to establish T1D cell therapy manufact...

Vertex and Lonza have entered a partnership to establish a facility in Portsmout...

Lisata shares pipeline update of anticancer lead candid...

Lisata aims to finish enrolment of its Phase II trial in solid tumours by the en...

Pfizer takes on haemophilia B gene therapy market with ...

The FDA has accepted a biologics license application (BLA) for Pfizer's fidanaco...

Rystiggo receives FDA approval, strengthening UCB’s mya...

UCB's Rystiggo has been granted FDA approval to treat myasthenia gravis in anti-...

Wane in Covid demand hurts Walgreens as profits drop to...

Walgreens Boots Alliance readjusted its 2023 outlook amidst mixed fiscal Q3 resu...

EMA CHMP issues positive opinion for AstraZeneca’s Soliris

The EMA CHMP has issued a positive opinion recommending marketing authorisation ...

Inflation reduction act boosts biologic drug venture fi...

In August 2022, the US Congress passed the Inflation Reduction Act (IRA), which ...

STAT+: U.K. agency declines to recommend Eli Lilly’s Mo...

A U.K. government agency said that it won’t recommend Eli Lilly’s Mounjaro for p...

STAT+: Fatty liver disease was alleviated by Lilly’s ‘t...

Nonalcoholic fatty liver disease is estimated to affect about 24% of U.S. adults...

STAT+: Illumina to lay off 10% of research and developm...

DNA sequencing giant Illumina has begun to lay off 10% of its research and devel...